top of page
Established in 2018, Amplicore Inc. is a biopharmaceutical start-up specialized in developing injectable regenerative therapeutic drugs to treat musculoskeletal diseases, such as degenerative joint osteoarthritis, cartilage damage, degenerative disc disease, acute meniscus tear, etc.
The proprietary technology that leads to Amplicore's novel formulation was based on the founder Dr. Chia-Ying James Lin's breaking findings and inventions at the University of Cincinnati. The technology has since aroused enormous interests and received various funding supports, including awards from National Institutes of Health, and the United States Department of Defense for its development.
About Us: About
bottom of page